Director/Associate Director, Cell Therapy CMC
3 weeks ago
Director/Associate Director, Cell Therapy CMC & ManufacturingWe are seeking a highly experienced and visionary leader of CMC & Manufacturing to lead our cell therapy development programs. The successful candidate will help lead CMC strategy, manage process development and manufacturing activities, and play a key role in advancing programs into first-in-human clinical trials. This role requires demonstrated success in bringing at least one cell therapy program from preclinical through IND and into clinical trials.Key ResponsibilitiesLead/support the development and implementation of CMC strategy for cell therapy programs.Lead process development and optimization for iPSC- or MSC-derived products and drive process development, scale-up, and tech transfer.Contribute to regulatory filings (CMC sections of IND/CTA).Collaborate with CMC, R&D, QC, QA, and clinical teams across China and the U.S. to ensure a seamless transition from preclinical to clinical development.Support resource planning, budgeting, and project management for CMC deliverables.Provide strategic leadership to ensure clinical readiness and robust supply chain for first-in-human studies.QualificationsPhD (preferred) or MS in Cell Biology, Immunology, Bioengineering, or related field.8+ years of biotech/pharma experience with at least 5 years in cell therapy CMC leadership.Hands-on experience with iPSC/MSC biology, process development, and GMP compliance.Proven track record of advancing programs into IND/clinical development.Deep knowledge of GMP regulations, regulatory expectations, and cell therapy manufacturing platforms.Excellent leadership, communication, and cross-functional team management skills.Strong interpersonal and communication skills; ability to thrive in a fast-paced, collaborative biotech environment.Strong leadership, project management, and cross-functional communication skills.We are an equal opportunities employer and welcome applications from all qualified candidates. #J-18808-Ljbffr
-
Boston, MA, United States QLD Biotherapeutics Inc Full timeDirector/Associate Director, Cell Therapy CMC & Manufacturing We are seeking a highly experienced and visionary leader of CMC & Manufacturing to lead our cell therapy development programs. The successful candidate will help lead CMC strategy, manage process development and manufacturing activities, and play a key role in advancing programs into...
-
Associate Director/Director, Regulatory CMC
3 weeks ago
Boston, United States Scorpion Therapeutics Full timeThis position is a key leadership role for the development of the In Vivo franchise at CRISPR. Reporting to the Head of Regulatory Affairs CMC, you will work closely with cross-functional teams and partners to bring multiple novel therapies to patients. As the Regulatory CMC lead for these programs, you will have the opportunity to devise and implement...
-
Boston, United States Vertex Full timeJob DescriptionGeneral Summary:Vertex Pharmaceuticals is seeking a highly motivated, collaborative, and innovative Associate Director specializing in analytical CMC strategy to provide scientific leadership within and across functional areas. The Analytical CMC Strategy Associate Director is the primary analytical liaison for their program(s) and will lead,...
-
Boston, United States Vertex Full timeSenior Director, Analytical Development (AD) Biologics and Cell and Gene TherapiesVertex is seeking a talented and experienced leader to join our Analytical Development (AD) Biologics and Cell and Gene Therapies Team in Boston, MA. The experienced leader will be a member of the AD Leadership Team and will play a central role in advancing our programs and...
-
Associate Director, Regulatory CMC
3 weeks ago
Boston, United States Solid Biosciences Full timeAssociate Director, Regulatory CMC – Solid Biosciences Charlestown, MA HQ Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic...
-
Boston, United States Dechra Full timeVacancies Associate Director/Director, Biologics CMC Regulatory Affairs Job Introduction This is a US remote role, with a preference for candidates based in the Boston area. Invetx, a division of Dechra , is a veterinary biotechnology company focused on developing protein-based therapeutics for chronic conditions in companion animals, with an emphasis on...
-
Director, Global Regulatory Affairs – Cell
3 weeks ago
Boston, United States Vivid Resourcing Full timeJob Title: Director, Global Regulatory Affairs – Cell & Gene Therapy DevelopmentLocation: Boston, Massachusetts | Hybrid / Remote FlexibilityIndustry: Biotechnology / Advanced TherapeuticsType: Full-time | PermanentAbout the Opportunity:We’re excited to partner with a pioneering biotechnology company developing transformative cell and gene therapies for...
-
Associate Director, Regulatory CMC
2 weeks ago
Boston, United States Solid Biosciences Full timeAssociate Director, Regulatory CMC – Solid Biosciences Location: Charlestown, MA HQ – hybrid option. Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic...
-
Director, Global Regulatory Affairs – Cell
1 week ago
Boston, United States Vivid Resourcing Full timeJob Title: Director, Global Regulatory Affairs – Cell & Gene Therapy DevelopmentLocation: Boston, Massachusetts | Hybrid / Remote FlexibilityIndustry: Biotechnology / Advanced TherapeuticsType: Full-time | PermanentMake sure to read the full description below, and please apply immediately if you are confident you meet all the requirements.About the...
-
Director, CMC Project Management
2 weeks ago
Boston, United States Jade Biosciences Full timeAbout Jade Biosciences Jade Biosciences is focused on developing innovative, best-in-class therapies to address critical unmet needs in autoimmune diseases. Our lead candidate, JADE101, is designed to inhibit the cytokine APRIL (A Proliferation?Inducing Ligand) and is being developed for the treatment of immunoglobulin A nephropathy (IgAN), a chronic kidney...